Multiple sclerosis and Substance-induced psychotic disorder
Summary:
Substance-induced psychotic disorder is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.
The study analyzes which people have Substance-induced psychotic disorder with Multiple sclerosis. It is created by eHealthMe based on reports of 42 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,085 drugs and 1,365 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
What is Substance-induced psychotic disorder?
Substance-induced psychotic disorder is found to be associated with 193 drugs and 332 conditions by eHealthMe. Check the latest studies of Substance-induced psychotic disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
42 people who have Multiple Sclerosis and Substance-Induced Psychotic Disorder are studied.

Gender of people who have Multiple Sclerosis and experienced Substance-Induced Psychotic Disorder *:
- female: 79.49 %
- male: 20.51 %
Age of people who have Multiple Sclerosis and experienced Substance-Induced Psychotic Disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 9.09 %
- 40-49: 33.33 %
- 50-59: 45.45 %
- 60+: 12.12 %
Common co-existing conditions for these people *:
- Depression: 5 people, 11.90%
- High Blood Pressure: 3 people, 7.14%
- Insomnia (sleeplessness): 3 people, 7.14%
- Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 3 people, 7.14%
- Fatigue (feeling of tiredness): 3 people, 7.14%
- Gait Disturbance: 3 people, 7.14%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 7.14%
- Multiple Allergies (allergy to multiple agents): 1 person, 2.38%
- Itching: 1 person, 2.38%
- Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.38%
Common drugs taken by these people *:
- Tysabri: 10 people, 23.81%
- Vitamin D3: 6 people, 14.29%
- Tecfidera: 6 people, 14.29%
- Ampyra: 5 people, 11.90%
- Gilenya: 5 people, 11.90%
- Mayzent: 4 people, 9.52%
- Avonex: 4 people, 9.52%
- Flomax: 4 people, 9.52%
- Kesimpta: 4 people, 9.52%
- Methylphenidate Hydrochloride: 3 people, 7.14%
Common symptoms for these people *:
- Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 23.81%
- Insomnia (sleeplessness): 7 people, 16.67%
- Fatigue (feeling of tiredness): 7 people, 16.67%
- Muscle Spasms (muscle contraction): 6 people, 14.29%
- Memory Loss: 6 people, 14.29%
- Weakness: 6 people, 14.29%
- Fall: 6 people, 14.29%
- Dizziness: 6 people, 14.29%
- Fever: 5 people, 11.90%
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 5 people, 11.90%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Substance-induced psychotic disorder?
- Check whether Substance-induced psychotic disorder is associated with a drug or a conditionRelated publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Multiple sclerosis (799,637 reports)
- Substance-induced psychotic disorder (2,218 reports)
All the drugs that are associated with Substance-induced psychotic disorder:
- Substance-induced psychotic disorder (193 drugs)
All the conditions that are associated with Substance-induced psychotic disorder:
- Substance-induced psychotic disorder (332 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Substance-induced psychotic disorder and Multiple sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Paranoia Aggravated in Vyvanse, how severe and when it was recovered? - 7 seconds ago
- Could Nasacort cause Nasal Congestion? - 14 seconds ago
- Drug interactions of Sulfatrim and Alendronate Sodium - 16 seconds ago
- Could Dexamethasone Sodium Phosphate cause Uveitis? - 21 seconds ago
- Could Magnesium cause Wound Complication? - 30 seconds ago
- Could Methotrexate cause Sebaceous Gland Disorder? - 40 seconds ago
- Symbicort and Azelastine Hydrochloride drug interactions for men aged 50-59 - a minute ago
- Drug interactions of Plavix and Granix - a minute ago
- Hiv Infection and Ultrasound Antenatal Screen Abnormal - a minute ago
- Could Doxycycline cause Uterine Infection? - a minute ago